Pfizer as of Sept. 30, 2025
Portfolio Holdings for Pfizer
Pfizer holds 21 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biontech Se Sponsored Ads (BNTX) | 37.4 | $164M | 1.7M | 98.62 | |
| Oric Pharmaceuticals (ORIC) | 14.7 | $65M | 5.4M | 12.00 | |
| Tourmaline Bio (TRML) | 13.9 | $61M | 1.3M | 47.83 | |
| Arvinas Ord (ARVN) | 6.7 | $30M | 3.5M | 8.52 | |
| Allogene Therapeutics (ALLO) | 6.2 | $27M | 22M | 1.24 | |
| Celcuity (CELC) | 3.9 | $17M | 349k | 49.40 | |
| Pyxis Oncology Common Stock (PYXS) | 3.6 | $16M | 7.0M | 2.22 | |
| Wave Life Sciences SHS (WVE) | 3.1 | $14M | 1.9M | 7.32 | |
| Zura Bio Class A Ord Shs (ZURA) | 2.9 | $13M | 3.0M | 4.33 | |
| Caribou Biosciences (CRBU) | 2.5 | $11M | 4.7M | 2.33 | |
| Biohaven (BHVN) | 1.7 | $7.6M | 506k | 15.01 | |
| Cardiff Oncology (CRDF) | 1.1 | $5.0M | 2.4M | 2.06 | |
| Spero Therapeutics (SPRO) | 1.0 | $4.4M | 2.4M | 1.88 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.3 | $1.4M | 954k | 1.51 | |
| Nextcure Com New | 0.2 | $924k | 158k | 5.86 | |
| An2 Therapeutics (ANTX) | 0.2 | $908k | 715k | 1.27 | |
| Q32 Bio (QTTB) | 0.1 | $550k | 278k | 1.98 | |
| Essa Pharma Com New (EPIX) | 0.1 | $320k | 1.7M | 0.19 | |
| Bolt Biotherapeutics Com New (BOLT) | 0.0 | $167k | 31k | 5.32 | |
| Ginkgo Bioworks Holdings Cl A New (DNA) | 0.0 | $43k | 2.9k | 14.58 | |
| Senseonics Hldgs (SENS) | 0.0 | $19k | 43k | 0.44 |
